Advertisement
For patients with heart failure with reduced ejection fraction

Sacubitril-Valsartan May Be Cost-Effective Option in HFrEF

0
More costly than enalapril but more effective over a lifetime in heart failure with reduced ejection fraction
New U.S. dietary guidelines have been released for 2015 to 2020

New Dietary Guidelines for Americans Issued for 2015-2020

0
Guidelines include limit on added sugars and encourage daily coffee consumption
Eating fresh fruit regularly may help prevent heart attacks and strokes

Daily Fresh Fruit Intake May Improve Cardiovascular Health

0
Lower risk of heart attack, stroke seen in Chinese study
Hearing loss is associated with higher medical costs for late middle-aged adults

Medical Costs Up for Late Middle-Aged With Hearing Loss

0
Researchers say more study needed to learn how hearing aids, other interventions might save money
A stimulant banned from competitive sports

Sport-Banned Oxilofrine Found in Diet Supplements

0
FDA has warned makers of 8 products containing oxilofrine, or methylsynephrine
Diabetes medications containing saxagliptin and alogliptin may raise the risk of heart failure

FDA Issues New Warning for Two Diabetes Medications

0
Drugs containing saxagliptin or alogliptin may be linked to heart failure risk
The number of adults worldwide with diabetes has quadrupled in the past 35 years

Since 1980, Diabetes Cases Have Quadrupled Globally

0
Major increases seen in low- and middle-income countries such as China and India
Local heating pad application eases catheterization in chemotherapy patients

Local Heating Pad Eases IV Catheter Insertion

0
Linked to less pain, easier placement in chemotherapy patients
Emotional distress is common in children during and after therapy for childhood acute lymphoblastic leukemia

Distress Still High After Chemo Completion in Childhood ALL

0
Need for targeted early screening, psychosocial interventions to help patients, families at this time
Expert consensus guidance has been issued regarding the use of non-statin therapies to lower cholesterol in high-risk patients. The consensus document was published online April 1 in the Journal of the American College of Cardiology to coincide with presentation at the annual meeting of the American College of Cardiology

ACC: Expert Guidance Issued for Use of Non-Statin Therapies

0
Authors recommend addition of ezetimibe at 10 mg/day for higher-risk patients